Literature DB >> 18003679

Mortality after myocardial infarction in patients with diabetes mellitus.

Akhil Kapur, Rodney De Palma.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18003679      PMCID： PMC2095769          DOI： 10.1136/hrt.2006.112656

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  40 in total

1.  The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.

Authors:  A Kapur; I S Malik; J P Bagger; J R Anderson; J S Kooner; M Thomas; P Punjabi; J Mayet; T Millane; J Goedicke; K Jamrozik; M A de Belder; R J Hall; K J Beatt
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

2.  Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study.

Authors:  Laura N McEwen; Catherine Kim; Mary Haan; Debashis Ghosh; Paula M Lantz; Carol M Mangione; Monika M Safford; David Marrero; Theodore J Thompson; William H Herman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

3.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

4.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

5.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

Review 6.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

7.  Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis.

Authors:  L F Hsu; K H Mak; K W Lau; L L Sim; C Chan; T H Koh; S C Chuah; R Kam; Z P Ding; W S Teo; Y L Lim
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

Authors:  R D Abbott; R P Donahue; W B Kannel; P W Wilson
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
View more
  6 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

2.  The Effects of Curcumin Plus Piperine Supplementation in Patients with Acute Myocardial Infarction: A Randomized, Double-Blind, and Placebo-Controlled Trial.

Authors:  Samaneh Tabaee; Amirhossein Sahebkar; Tayebe Aghamohammadi; Manizhe Pakdel; Maryam Dehabeh; Reza Sobhani; Mona Alidadi; Muhammed Majeed; Seyed Reza Mirhafez
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  THE ABCDE'S OF PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE.

Authors:  Roger S Blumenthal; Abdulhamied Alfaddagh
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

4.  Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive Biomarker.

Authors:  Agnieszka Bielska; Magdalena Niemira; Witold Bauer; Iwona Sidorkiewicz; Anna Szałkowska; Anna Skwarska; Justyna Raczkowska; Damian Ostrowski; Kamil Gugała; Sławomir Dobrzycki; Adam Krętowski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-18       Impact factor: 6.055

5.  Up-regulation of microRNA-135a protects against myocardial ischemia/reperfusion injury by decreasing TXNIP expression in diabetic mice.

Authors:  Hong-Jun Zhu; De-Guo Wang; Ji Yan; Jian Xu
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

6.  Microbial Signatures in The Rodent Eyes With Retinal Dysfunction and Diabetic Retinopathy.

Authors:  Ram Prasad; Bright Asare-Bediko; Angela Harbour; Jason L Floyd; Dibyendu Chakraborty; Yaqian Duan; Regina Lamendella; Justin Wright; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.